Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 20 Apr 2026 for TriSalus Life Sciences, Inc.. Read the official filing
Filing timeline
BuySaleFrankenius Equity AB
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +84.2%Entry US$4.05 · Close at T+365 US$7.46
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Frankenius Equity AB: trading record in brief
Frankenius Equity AB discloses dealings in TriSalus Life Sciences, Inc. to SEC (Form 4). Between 17 December 2024 and 31 July 2025, the trades on record add up to 2 filings.
Purchases make up the whole of the open-market record (1 purchase, €238k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The record was last updated on 20 April 2026 with a transaction in TriSalus Life Sciences, Inc. The latest purchase dates back some time: it was published 668 days ago, on 19 December 2024. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Frankenius Equity AB
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
759,000 shares0Common StockSEC:0001628280-26-026014:0
62,972 shares@ US$3.97100.0% of flowCommon StockSEC:0001415889-24-029904:0
Canonical exit: 17 Mar 2025 (T+90)
2 of 2 declarations
